In medulloblastoma, a unique, albeit more defined, metabolic pattern controlled by Shh is beginning to emerge: The striking accumulation of lipid droplets we describe earlier ([2] and Fig. 1a), is matched by the equally striking glycolytic index and confirmed by elevated FDG-PET activity. This evidence concerns the gene SHH and medulloblastoma.